K.TO vs. GILD
K.TO (Kinross Gold Corporation) and GILD (Gilead Sciences, Inc.) are both stocks. K.TO operates in Gold (Basic Materials), while GILD operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, K.TO returned 19.71%/yr vs 8.99%/yr for GILD. At a 0.04 correlation, their price movements are largely independent.
Performance
K.TO vs. GILD - Performance Comparison
Loading charts...
Different Trading Currencies
K.TO is traded in CAD, while GILD is traded in USD. To make them comparable, the GILD values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, K.TO achieves a -6.51% return, which is significantly lower than GILD's 6.87% return. Over the past 10 years, K.TO has outperformed GILD with an annualized return of 19.71%, while GILD has yielded a comparatively lower 8.99% annualized return.
K.TO
- 1D
- -1.23%
- 1M
- -16.30%
- YTD
- -6.51%
- 6M
- -1.43%
- 1Y
- 75.29%
- 3Y*
- 79.50%
- 5Y*
- 33.08%
- 10Y*
- 19.71%
GILD
- 1D
- -0.55%
- 1M
- -0.43%
- YTD
- 6.87%
- 6M
- 7.85%
- 1Y
- 19.31%
- 3Y*
- 23.74%
- 5Y*
- 20.95%
- 10Y*
- 8.99%
K.TO vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
K.TO Kinross Gold Corporation | -6.51% | 191.80% | 69.08% | 49.14% | -22.75% | -20.24% | 52.79% | 40.00% | -18.82% | 29.36% |
GILD Gilead Sciences, Inc. | 6.87% | 30.36% | 28.73% | -4.32% | 31.46% | 29.89% | -8.91% | 3.43% | -2.35% | -4.01% |
Correlation
The correlation between K.TO and GILD is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Jul 6, 2006 | 0.04 |
Fundamentals
K.TO:
CA$43.41B
GILD:
$160.64B
K.TO:
CA$2.36
GILD:
$7.35
K.TO:
15.26
GILD:
17.43
K.TO:
0.20
GILD:
0.04
K.TO:
5.50
GILD:
5.40
K.TO:
4.77
GILD:
6.83
K.TO:
CA$7.97B
GILD:
$29.74B
K.TO:
CA$4.26B
GILD:
$18.74B
K.TO:
CA$5.03B
GILD:
$12.88B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
K.TO vs. GILD — Risk / Return Rank
K.TO
GILD
K.TO vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kinross Gold Corporation (K.TO) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| K.TO | GILD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.77 | ||
| Sortino ratioReturn per unit of downside risk | +0.69 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.14 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 2.49 | 1.14 | +1.35 |
| Martin ratioReturn relative to average drawdown | 6.53 | 2.83 | +3.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| K.TO | GILD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.50 | 0.73 | +0.77 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.79 | 0.84 | -0.05 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.34 | +0.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 0.51 | -0.38 |
Drawdowns
K.TO vs. GILD - Drawdown Comparison
The maximum K.TO drawdown since its inception was -92.37%, which is greater than GILD's maximum drawdown of -48.16%. Use the drawdown chart below to compare losses from any high point for K.TO and GILD.
Loading charts...
Drawdown Indicators
| K.TO | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.37% | -48.16% | -44.21% |
Max Drawdown (1Y)Largest decline over 1 year | -30.38% | -17.02% | -13.36% |
Max Drawdown (3Y)Largest decline over 3 years | -30.38% | -25.87% | -4.51% |
Max Drawdown (5Y)Largest decline over 5 years | -57.67% | -25.87% | -31.80% |
Max Drawdown (10Y)Largest decline over 10 years | -68.36% | -36.49% | -31.87% |
Current DrawdownCurrent decline from peak | -30.38% | -15.15% | -15.23% |
Average DrawdownAverage peak-to-trough decline | -55.97% | -19.05% | -36.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.56% | 6.84% | +4.72% |
Volatility
K.TO vs. GILD - Volatility Comparison
Kinross Gold Corporation (K.TO) has a higher volatility of 16.35% compared to Gilead Sciences, Inc. (GILD) at 6.81%. This indicates that K.TO's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| K.TO | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.35% | 6.81% | +9.54% |
Volatility (6M)Calculated over the trailing 6-month period | 38.46% | 18.57% | +19.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.39% | 26.50% | +23.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.32% | 25.06% | +17.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.55% | 26.32% | +19.23% |
Dividends
K.TO vs. GILD - Dividend Comparison
K.TO's dividend yield for the trailing twelve months is around 0.56%, less than GILD's 2.49% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.49% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
K.TO Kinross Gold Corporation | 0.56% | 0.45% | 1.23% | 2.04% | 2.68% | 1.63% | 0.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
K.TO vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Kinross Gold Corporation and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
K.TO vs. GILD - Profitability Comparison
K.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kinross Gold Corporation reported a gross profit of 1.44B and revenue of 2.41B. Therefore, the gross margin over that period was 59.9%.
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.
K.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kinross Gold Corporation reported an operating income of 1.33B and revenue of 2.41B, resulting in an operating margin of 55.1%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.
K.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kinross Gold Corporation reported a net income of 843.00M and revenue of 2.41B, resulting in a net margin of 35.0%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.
Frequently Asked Questions
K.TO and GILD have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for K.TO and GILD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer